中国医药科学Issue(12)：125-126,165,3.
成纤维细胞生长因子应用于冠心病治疗的研究分析
The research status of fibroblast growth factor applied in the treatment of coronary heart disease
徐化静 1冯均庆 1牛红星 1杨殿滨 1吉占全1
作者信息
- 1. 河南省安阳地区医院心胸外科，河南安阳 455000
- 折叠
摘要
Abstract
Objective To investigate the research status of fiber cell growth factor in the treatment of coronary heart disease. Methods 80 cases with coronary heart disease patients in our hospital from May 2013 to May 2014 were selected, random allocation, the effect with usual care (control group,n=40) and in combination with fibroblast growth factor treatment (observation group,n=40) were compared.ResultsThe total effective rate of selected patients was 97.5%, significantly higher than 80.0% (P<0.05). Two heart function CRP, LVPW, LVESD, LVEDD treatment had no significant difference (P>0.05) before, were improved after treatment, but the magnitude of the improvement in the observation group was better than that in the control group (P<0.05).ConclusionCoronary heart disease using fibroblast growth factor therapy, can significantly improve the prognosis, improve heart function, for the clinical treatment has opened up new ways to make significant improvement in the quality of life of patients, to ensure the safety of very important significance.关键词
成纤细胞生长因子/冠心病/研究现状Key words
Fibroblast growth factor/Coronary heart disease/Research status分类
医药卫生引用本文复制引用
徐化静,冯均庆,牛红星,杨殿滨,吉占全..成纤维细胞生长因子应用于冠心病治疗的研究分析[J].中国医药科学,2015,(12):125-126,165,3.
